MoneyWorks4Me

Tatva Chintan Pharma - Quaterly Results

24 Jul 2025 Evaluate
A fair growth of 16.39% in the revenue at Rs. 1091.80 millions was reported in the June 2025 quarter as compared to Rs. 938.08 millions during year-ago period.The Net Profit of the company vaulted to 240.38% to Rs. 51.33  millions from Rs. 15.08 millions in the previous quarter.Operating profit surged to 164.36 millions from the corresponding previous quarter of 91.15 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 1091.80 938.08 16.39 1091.80 938.08 16.39 3664.15 3786.77 -3.24
Other Income 13.69 14.20 -3.59 13.69 14.20 -3.59 35.61 75.08 -52.57
PBIDT 164.36 91.15 80.32 164.36 91.15 80.32 294.05 743.73 -60.46
Interest 4.13 3.14 31.53 4.13 3.14 31.53 12.90 65.07 -80.18
PBDT 160.23 88.01 82.06 160.23 88.01 82.06 281.15 678.66 -58.57
Depreciation 89.69 66.64 34.59 89.69 66.64 34.59 276.54 256.01 8.02
PBT 70.54 21.37 230.09 70.54 21.37 230.09 4.61 422.65 -98.91
TAX 19.21 6.29 205.41 19.21 6.29 205.41 1.34 129.17 -98.96
Deferred Tax 7.09 2.69 163.57 7.09 2.69 163.57 1.32 55.73 -97.63
PAT 51.33 15.08 240.38 51.33 15.08 240.38 3.27 293.48 -98.89
Equity 233.92 233.92 0.00 233.92 233.92 0.00 233.92 233.92 0.00
PBIDTM(%) 15.05 9.72 54.93 15.05 9.72 54.93 8.03 19.64 -59.14
Peers
Company Name CMP
Godrej Industries 1085.75
SRF 2483.95
BASF India 3482.30
Pidilite Inds. 1486.05
Tata Chemicals 628.60
View more..